Medical Care

Global Medical Radioisotopes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

The global Medical Radioisotopes market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
By Type: (Dominant Segment vs High-Margin Innovation)
Tc-99m
Cobalt-60
Iodine Radioisotopes
By Application: (Core Demand Driver vs Emerging Opportunity)
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., NRG in Europe)
- Emerging Product Trends: Tc-99m adoption vs. Cobalt-60 premiumization
- Demand-Side Dynamics: Nuclear Therapy growth in China vs. Equipment Radioactive Source potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Australia
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Medical Radioisotopes market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cobalt-60 in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Equipment Radioactive Source in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Medical Radioisotopes value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Radioisotopes Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Medical Radioisotopes Revenue Market Share by Region (2020-2025)
2.4 Global Medical Radioisotopes Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Medical Radioisotopes Market Size and Prospective (2020-2031)
2.5.2 Europe Medical Radioisotopes Market Size and Prospective (2020-2031)
2.5.3 China Medical Radioisotopes Market Size and Prospective (2020-2031)
2.5.4 Australia Medical Radioisotopes Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Medical Radioisotopes Historic Market Size by Type (2020-2025)
3.2 Global Medical Radioisotopes Forecasted Market Size by Type (2026-2031)
3.3 Different Types Medical Radioisotopes Representative Players
4 Breakdown Data by Application
4.1 Global Medical Radioisotopes Historic Market Size by Application (2020-2025)
4.2 Global Medical Radioisotopes Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Medical Radioisotopes Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Medical Radioisotopes Players by Revenue (2020-2025)
5.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Medical Radioisotopes Revenue
5.4 Global Medical Radioisotopes Market Concentration Analysis
5.4.1 Global Medical Radioisotopes Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Medical Radioisotopes Revenue in 2024
5.5 Global Key Players of Medical Radioisotopes Head office and Area Served
5.6 Global Key Players of Medical Radioisotopes, Product and Application
5.7 Global Key Players of Medical Radioisotopes, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Medical Radioisotopes Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Medical Radioisotopes Market Size by Type (2020-2025)
6.1.2.2 North America Medical Radioisotopes Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Medical Radioisotopes Market Size by Application (2020-2025)
6.1.3.2 North America Medical Radioisotopes Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Medical Radioisotopes Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Medical Radioisotopes Market Size by Type (2020-2025)
6.2.2.2 Europe Medical Radioisotopes Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Medical Radioisotopes Market Size by Application (2020-2025)
6.2.3.2 Europe Medical Radioisotopes Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Medical Radioisotopes Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Medical Radioisotopes Market Size by Type (2020-2025)
6.3.2.2 China Medical Radioisotopes Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Medical Radioisotopes Market Size by Application (2020-2025)
6.3.3.2 China Medical Radioisotopes Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Australia Market: Players, Segments and Downstream
6.4.1 Australia Medical Radioisotopes Revenue by Company (2020-2025)
6.4.2 Australia Market Size by Type
6.4.2.1 Australia Medical Radioisotopes Market Size by Type (2020-2025)
6.4.2.2 Australia Medical Radioisotopes Market Share by Type (2020-2025)
6.4.3 Australia Market Size by Application
6.4.3.1 Australia Medical Radioisotopes Market Size by Application (2020-2025)
6.4.3.2 Australia Medical Radioisotopes Market Share by Application (2020-2025)
6.4.4 Australia Market Trend and Opportunities
7 Key Players Profiles
7.1 NRG
7.1.1 NRG Company Details
7.1.2 NRG Business Overview
7.1.3 NRG Medical Radioisotopes Introduction
7.1.4 NRG Revenue in Medical Radioisotopes Business (2020-2025)
7.1.5 NRG Recent Development
7.2 IRE
7.2.1 IRE Company Details
7.2.2 IRE Business Overview
7.2.3 IRE Medical Radioisotopes Introduction
7.2.4 IRE Revenue in Medical Radioisotopes Business (2020-2025)
7.2.5 IRE Recent Development
7.3 ANSTO
7.3.1 ANSTO Company Details
7.3.2 ANSTO Business Overview
7.3.3 ANSTO Medical Radioisotopes Introduction
7.3.4 ANSTO Revenue in Medical Radioisotopes Business (2020-2025)
7.3.5 ANSTO Recent Development
7.4 NTP Radioisotopes
7.4.1 NTP Radioisotopes Company Details
7.4.2 NTP Radioisotopes Business Overview
7.4.3 NTP Radioisotopes Medical Radioisotopes Introduction
7.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2020-2025)
7.4.5 NTP Radioisotopes Recent Development
7.5 China National Nuclear Corporation
7.5.1 China National Nuclear Corporation Company Details
7.5.2 China National Nuclear Corporation Business Overview
7.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction
7.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2020-2025)
7.5.5 China National Nuclear Corporation Recent Development
7.6 Rosatom
7.6.1 Rosatom Company Details
7.6.2 Rosatom Business Overview
7.6.3 Rosatom Medical Radioisotopes Introduction
7.6.4 Rosatom Revenue in Medical Radioisotopes Business (2020-2025)
7.6.5 Rosatom Recent Development
7.7 Nordion
7.7.1 Nordion Company Details
7.7.2 Nordion Business Overview
7.7.3 Nordion Medical Radioisotopes Introduction
7.7.4 Nordion Revenue in Medical Radioisotopes Business (2020-2025)
7.7.5 Nordion Recent Development
7.8 Eckert & Ziegler Strahlen
7.8.1 Eckert & Ziegler Strahlen Company Details
7.8.2 Eckert & Ziegler Strahlen Business Overview
7.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
7.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2020-2025)
7.8.5 Eckert & Ziegler Strahlen Recent Development
7.9 Polatom
7.9.1 Polatom Company Details
7.9.2 Polatom Business Overview
7.9.3 Polatom Medical Radioisotopes Introduction
7.9.4 Polatom Revenue in Medical Radioisotopes Business (2020-2025)
7.9.5 Polatom Recent Development
8 Medical Radioisotopes Market Dynamics
8.1 Medical Radioisotopes Industry Trends
8.2 Medical Radioisotopes Market Drivers
8.3 Medical Radioisotopes Market Challenges
8.4 Medical Radioisotopes Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Medical Radioisotopes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Medical Radioisotopes Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Medical Radioisotopes Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Medical Radioisotopes Revenue Share by Region (2020-2025)
Table 6. Global Medical Radioisotopes Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Medical Radioisotopes Revenue Share Forecast by Region (2026-2031)
Table 8. Global Medical Radioisotopes Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Medical Radioisotopes Revenue Market Share by Type (2020-2025)
Table 10. Global Medical Radioisotopes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Medical Radioisotopes Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Medical Radioisotopes Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Medical Radioisotopes Revenue Market Share by Application (2020-2025)
Table 15. Global Medical Radioisotopes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Medical Radioisotopes Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Medical Radioisotopes Application
Table 18. Global Medical Radioisotopes Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Medical Radioisotopes Market Share by Players (2020-2025)
Table 20. Global Top Medical Radioisotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Radioisotopes as of 2024)
Table 21. Ranking of Global Top Medical Radioisotopes Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Medical Radioisotopes Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Medical Radioisotopes, Headquarters and Area Served
Table 24. Global Key Players of Medical Radioisotopes, Product and Application
Table 25. Global Key Players of Medical Radioisotopes, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Medical Radioisotopes Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Medical Radioisotopes Revenue Market Share by Company (2020-2025)
Table 29. North America Medical Radioisotopes Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Medical Radioisotopes Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Medical Radioisotopes Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Medical Radioisotopes Revenue Market Share by Company (2020-2025)
Table 33. Europe Medical Radioisotopes Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Medical Radioisotopes Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Medical Radioisotopes Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Medical Radioisotopes Revenue Market Share by Company (2020-2025)
Table 37. China Medical Radioisotopes Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Medical Radioisotopes Market Size by Application (2020-2025) & (US$ Million)
Table 39. Australia Medical Radioisotopes Revenue by Company (2020-2025) & (US$ Million)
Table 40. Australia Medical Radioisotopes Revenue Market Share by Company (2020-2025)
Table 41. Australia Medical Radioisotopes Market Size by Type (2020-2025) & (US$ Million)
Table 42. Australia Medical Radioisotopes Market Size by Application (2020-2025) & (US$ Million)
Table 43. NRG Company Details
Table 44. NRG Business Overview
Table 45. NRG Medical Radioisotopes Product
Table 46. NRG Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 47. NRG Recent Development
Table 48. IRE Company Details
Table 49. IRE Business Overview
Table 50. IRE Medical Radioisotopes Product
Table 51. IRE Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 52. IRE Recent Development
Table 53. ANSTO Company Details
Table 54. ANSTO Business Overview
Table 55. ANSTO Medical Radioisotopes Product
Table 56. ANSTO Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 57. ANSTO Recent Development
Table 58. NTP Radioisotopes Company Details
Table 59. NTP Radioisotopes Business Overview
Table 60. NTP Radioisotopes Medical Radioisotopes Product
Table 61. NTP Radioisotopes Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 62. NTP Radioisotopes Recent Development
Table 63. China National Nuclear Corporation Company Details
Table 64. China National Nuclear Corporation Business Overview
Table 65. China National Nuclear Corporation Medical Radioisotopes Product
Table 66. China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 67. China National Nuclear Corporation Recent Development
Table 68. Rosatom Company Details
Table 69. Rosatom Business Overview
Table 70. Rosatom Medical Radioisotopes Product
Table 71. Rosatom Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 72. Rosatom Recent Development
Table 73. Nordion Company Details
Table 74. Nordion Business Overview
Table 75. Nordion Medical Radioisotopes Product
Table 76. Nordion Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 77. Nordion Recent Development
Table 78. Eckert & Ziegler Strahlen Company Details
Table 79. Eckert & Ziegler Strahlen Business Overview
Table 80. Eckert & Ziegler Strahlen Medical Radioisotopes Product
Table 81. Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 82. Eckert & Ziegler Strahlen Recent Development
Table 83. Polatom Company Details
Table 84. Polatom Business Overview
Table 85. Polatom Medical Radioisotopes Product
Table 86. Polatom Revenue in Medical Radioisotopes Business (2020-2025) & (US$ Million)
Table 87. Polatom Recent Development
Table 88. Medical Radioisotopes Market Trends
Table 89. Medical Radioisotopes Market Drivers
Table 90. Medical Radioisotopes Market Challenges
Table 91. Medical Radioisotopes Market Restraints
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources


List of Figures
Figure 1. Medical Radioisotopes Product Picture
Figure 2. Global Medical Radioisotopes Market Share by Type: 2024 VS 2031
Figure 3. Tc-99m Features
Figure 4. Cobalt-60 Features
Figure 5. Iodine Radioisotopes Features
Figure 6. Global Medical Radioisotopes Market Share by Application: 2024 VS 2031
Figure 7. Nuclear Therapy
Figure 8. Equipment Radioactive Source
Figure 9. Diagnosis
Figure 10. Others
Figure 11. Medical Radioisotopes Report Years Considered
Figure 12. Global Medical Radioisotopes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Medical Radioisotopes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Medical Radioisotopes Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Medical Radioisotopes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Medical Radioisotopes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Medical Radioisotopes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Australia Medical Radioisotopes Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Medical Radioisotopes Market Share by Players in 2024
Figure 20. Global Top Medical Radioisotopes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Radioisotopes as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Medical Radioisotopes Revenue in 2024
Figure 22. North America Medical Radioisotopes Market Share by Type (2020-2025)
Figure 23. North America Medical Radioisotopes Market Share by Application (2020-2025)
Figure 24. Europe Medical Radioisotopes Market Share by Type (2020-2025)
Figure 25. Europe Medical Radioisotopes Market Share by Application (2020-2025)
Figure 26. China Medical Radioisotopes Market Share by Type (2020-2025)
Figure 27. China Medical Radioisotopes Market Share by Application (2020-2025)
Figure 28. Australia Medical Radioisotopes Market Share by Type (2020-2025)
Figure 29. Australia Medical Radioisotopes Market Share by Application (2020-2025)
Figure 30. NRG Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 31. IRE Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 32. ANSTO Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 33. NTP Radioisotopes Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 34. China National Nuclear Corporation Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 35. Rosatom Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 36. Nordion Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 37. Eckert & Ziegler Strahlen Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 38. Polatom Revenue Growth Rate in Medical Radioisotopes Business (2020-2025)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies